Adherence of Ovarian Cancer Cells Induces Pleural Mesothelial Cell (PMC) Permeability

Oncology Research

Volumn 13, Issue 2, 2002, Pages 79-85

  Sriram, P S ^a   Mohammed, Kamal A ^a   Nasreen, Najmunnisa ^a   Hardwick, Joyce ^a   Van Horn, Robert ^a   Sanders, Kerry ^a   Antony, Veena B ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Mesothelial cells; Ovarian cancer cells; Protein permeability; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN ANTIBODY; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; PROTEIN; SIGNAL PEPTIDE; VASCULOTROPIN A;

ARTICLE; BREAST CANCER; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; LUNG CANCER; MESOTHELIUM CELL; OVARY CANCER; PLEURA CAVITY; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURVIVAL RATE; ANIMAL; BIOSYNTHESIS; COCULTURE; CYTOLOGY; EPITHELIUM CELL; FEMALE; METABOLISM; MOUSE; OVARY TUMOR; PATHOLOGY; PERMEABILITY; PLEURA;

ANIMALS; CELL ADHESION; COCULTURE TECHNIQUES; ENDOTHELIAL GROWTH FACTORS; EPITHELIAL CELLS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; OVARIAN NEOPLASMS; PERMEABILITY; PLEURA; PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036371320     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Anthony, V. B.; Loddenkemper, R.; Astoui, P.; Boutin, C.; Goldstraw, P.; Hott, J.; Rodriguez Panadero, F.; Sahn, S. A. Management of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 162:1987-2001; 2000.
2. Maghfoor, I.; Doll, D. C.; Yarbro, J. W. In: Abeloff, M. D., ed. Clinical oncology, 2nd ed. London: Churchill Livingstone; 2000:922-944.
3. Sahn, S. A. State of the art. The pleura. Am. Rev. Respir. Dis. 138:184-234; 1988.
4. Cancer Reference Information, American Cancer Society. What are the key statistics about ovarian cancer? http:www.cancer.org/ eprise/main; 2001.
5. Ozols, R. F.; Schwartz, P. E.; Eifel, P. J. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: Devita, V. T., Jr.; Hellman, S.; Rosenberg, S. A., eds. Cancer: Principles and practice of oncology, 5th ed. Philadelphia: Lippincot-Raven; 1997:1502-1539.
6. Mattern, J.; Koomagi, R.; Volm, M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer 73:931-934; 1996.
7. Ferrara, N.; Houck, K.; Jakeman, L.; Leung, D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:18-32; 1992.
8. Ferrara, N.; Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25; 1997.
9. Keck, P. J.; Hauser, S. D.; Krivi, G.; Sanzo, K.; Warren, T.; Feder, J.; Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312; 1989.
10. Leung, D. W.; Cachianes, G.; Kuang, W. J.; Goeddel, D. V.; Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309; 1989.
11. Brown, L. F.; Berse, B.; Jackman, R. W.; Tognazzi, K.; Guidi, A. J.; Dvorak, H. F.; Senger, D. R.; Connolly, J. L.; Schnitt, S. J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26:86-91; 1995.
12. Olson, T. A.; Mohanraj, D.; Carson, L. F.; Ramakrishnan, S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res. 54:276-280; 1994.
13. Roberts, W. G.; Palade, G. E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell. Sci. 108:2369-2379; 1995.
14. Wang, N. S. Mesothelial cells in situ, the pleura in health and disease. In: Lung biology in health and disease, 1st ed. New York: Marcel Dekker Inc.; 1985:23-42.
15. Lewalle, J. M.; Bajou, K.; Desreux, J.; Mareel, M.; Dejana, E.; Noel A.; Foidart, J. M. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp. Cell Res. 237:347-356; 1997.
16. BCECF and BCPCF, Molecular Probes product information. www. probes.com; 2000.
17. De Clerck, L. S.; Bridts, C. H.; Mertens, A. M.; Moens, M. M.; Stevens, W. J. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J. Immunol. Methods 172:115-124; 1994.
18. Patterson, C. E.; Stasek, J. E.; Schaphorst, K. L.; Davis, H. W.; Garcia, J. G. Mechanisms of pertussis toxin-induced barrier dysfunction in bovine pulmonary artery endothelial cell monolayers. Am. J. Physiol. 268:L926-934; 1995.
19. Mohammed, K. A.; Nasreen, N.; Ward, M. J.; Mubarak, K. K.; Rodriguez-Panadero, F.; Antony, V. B. Mycobacterium-mediated chemokine expression in pleural mesothelial cells: Role of C-C chemokines in tuberculous pleurisy. J. Infect. Dis. 178:1450-1456; 1998.
20. Johnston, W. W. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 56:905-909; 1985.
21. Hsu, C. Cytologic detection of malignancy in pleural effusion: A review of 5,255 samples from 3,811 patients. Diagn. Cytopathol. 3:8-12; 1987.
22. Van de Molengraft, F. J.; Vooijs, G. P. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis. Acta Cytol. 32:183-187; 1988.
23. Senger, D. R.; Galli, S. J.; Dvorak, A. M.; Perruzzi, C. A.; Harvey, V. S.; Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985; 1983.
24. Viglietto, G.; Maglione, D.; Rambaldi, M.; Cerutti, J.; Romano, A.; Trapasso, F.; Fedele, M.; Ippolito, P.; Chiappetta, G.; Botti, G. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (P1GF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11:1569-1579; 1995.
25. Viglietto, G.; Romano, A.; Maglione, D.; Rambaldi, M.; Paoletti, I.; Lago, C. T.; Califano, D.; Monaco, C.; Mineo, A.; Santelli, G.; Manzo, G.; Botti, G.; Chiappetta, G.; Persico, M. G. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene 13:577-587; 1996.
26. Toi, M.; Hoshina, S.; Takayanagi, T.; Tominaga, T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res. 85:1045-1049; 1994.
27. Maeda, K.; Chung, Y. S.; Ogawa, Y.; Takatsuka, S.; Kang, S. M.; Ogawa, M.; Sawada, T.; Sowa, M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858-863; 1996.
28. Kim, K. J.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.; Phillips, H. S.; Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844; 1993.
29. Warren, R. S.; Yuan, H.; Matli, M. R.; Gillett, N. A.; Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95:1789-1797; 1995.
30. Borgstrom, P.; Hillan, K. J.; Sriramarao, P.; Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by antivascular endothelial growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56:4032-4039; 1996.
31. Melnyk, O.; Shuman, M. A.; Kim, K. J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res. 56:921-924; 1996.
32. Cohen, A. W.; Carbajal, J. M.; Schaeffer, R. C., Jr. VEGF stimulates tyrosine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction. Am. J. Physiol. 277:H2038-2049; 1999.